Semaglutide alleviates knee osteoarthritis pain in persons with metabolic research models [PMID: 39810052] Laboratory literature summary: Semaglutide alleviates knee osteoarthritis pain in persons with metabolic research models
Earlier formulations required frequent dosing, but newer agents like Dulaglutide and Semaglutide allow once-weekly dosing, and regulators have approved an oral Semaglutide formulation (18)(21)(27)
Respecto al efecto de la L-carnitina para atenuar la produccin de cido lctico, Ransone y Lefavi (1997), no observaron este efecto al estudiar a 26 corredores que realizaron pruebas de 400 m o 1500 m, en donde la ingesta oral de 2 gr de L-carnitina por da no produjo variaciones significativas en los niveles de cido lctico medidos 1, 3 y 5 minutos luego de finalizar el esfuerzo (Ransone & Lefavi 1997)
The difference significantly impacts both safety and treatment outcomes
FIGURE 3 Both peripherally secreted GLP-1 and pharmacologic GLP-1RAs can cross the bloodbrain barrier (BBB) or interact with circumventricular organs, suggesting that peripheral administration is sufficient to reach CNS targets
